Poplar Forest Capital’s Pfizer PFE Stock Holding History

Poplar Forest Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-72,831	Closed	-$2.23M	–	75
2015 Q4	$2.23M	Sell	72,831 -12,996	-15%	-$409K	0.2%	38
2015 Q3	$2.56M	Hold	85,827	–	–	0.24%	34
2015 Q2	$2.73M	Hold	85,827	–	–	0.21%	32
2015 Q1	$2.83M	Sell	85,827 -2,161	-2%	-$68.7K	0.21%	39
2014 Q4	$2.6M	Hold	87,988	–	–	0.22%	43
2014 Q3	$2.47M	Hold	87,988	–	–	0.22%	42
2014 Q2	$2.48M	Hold	87,988	–	–	0.25%	35
2014 Q1	$2.68M	Hold	87,988	–	–	0.29%	32
2013 Q4	$2.56M	Hold	87,988	–	–	0.32%	32
2013 Q3	$2.4M	Hold	87,988	–	–	0.3%	32
2013 Q2	$2.34M	Buy	+87,988	New	+$2.43M	0.33%	32

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Poplar Forest Capital's PFE Position: Q1 2016 in Review

Poplar Forest Capital sold out of Pfizer (PFE) in Q1 2016, closing a stake of 72,831 shares — an estimated $2.23M sold.

Poplar Forest Capital first reported a position in PFE in Q2 2013 and held it in 11 quarters. The position peaked at $2.83M in Q1 2015. 1,967 funds tracked by Wall St. Rank hold PFE as of Q1 2016.

Poplar Forest Capital reported no remaining Pfizer position as of Q1 2016 after selling out during the quarter.
Poplar Forest Capital sold 72,831 Pfizer shares in Q1 2016, an estimated $2.23M.
Poplar Forest Capital first reported a position in Pfizer in Q2 2013 and held it in 11 quarters.
Poplar Forest Capital's Pfizer position peaked at $2.83M in Q1 2015.
1,967 funds tracked by Wall St. Rank held Pfizer as of Q1 2016.

Based on Poplar Forest Capital's 13F filing for Q1 2016, filed 13 May 2016.